+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tygacil"

From
Tygacil - API Insight, 2022 - Product Thumbnail Image

Tygacil - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tygacil- Drug Insight, 2019 - Product Thumbnail Image

Tygacil- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Tygacil (Tigecycline) is an antibiotic used to treat a variety of bacterial infections. It is a tetracycline antibiotic, which works by inhibiting the growth of bacteria. Tygacil is used to treat complicated skin and soft tissue infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia. It is also used to treat infections caused by multidrug-resistant organisms. Tygacil is marketed by Pfizer, Inc. in the United States and by Astellas Pharma Inc. in Japan. It is also available in generic form from several generic manufacturers. The Tygacil market is highly competitive, with several companies offering generic versions of the drug. These companies include Mylan, Teva Pharmaceuticals, Sandoz, and Dr. Reddy's Laboratories. Other companies that offer branded versions of the drug include Astellas Pharma Inc., Pfizer, and Merck & Co. Show Less Read more